{"id":"W4307889418","doi":"10.1093/ckj/sfac234","title":"A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease","year":2022,"lang":"en","type":"article","venue":"Clinical Kidney Journal","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"University of Chicago Medicine; Abbott Vascular; National Institutes of Health; Impulse Dynamics; Idorsia Pharmaceuticals; Bayer; Gilead Sciences; Servier; Vifor Pharma; Fresenius Medical Care North America; Astellas Pharma; Novo Nordisk; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Eli Lilly and Company; AstraZeneca; Chiesi Farmaceutici; CSL Behring; Relypsa; University of Chicago; Akebia Therapeutics; European Commission; Steno Diabetes Center Copenhagen; Bayer HealthCare; Sanofi; Amgen","keywords":"Spironolactone; Medicine; Hyperkalemia; Discontinuation; Kidney disease; Internal medicine; Placebo; Mineralocorticoid receptor; Hazard ratio; Confidence interval; Cardiology; Urology; Endocrinology; Heart failure; Aldosterone; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00651021,0.001184711,0.00544287,0.0004559333,0.0002253847,0.0008210897,0.0008081348,0.0009060851,0.006894272],"category_scores_gemma":[0.007446681,0.0004054673,0.006156769,0.0004141813,0.0005393737,0.0007672847,0.0006906412,0.001366751,0.0003516833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005666772,"about_ca_system_score_gemma":0.0006916796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009706533,"about_ca_topic_score_gemma":0.001713152,"domain_scores_codex":[0.993523,0.004752341,0.0004239517,0.0006281632,0.0003021873,0.0003703123],"domain_scores_gemma":[0.9929639,0.004379854,0.00101955,0.0006670402,0.0004537653,0.0005159715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9791236,0.001128009,0.00139612,0.0007118327,0.01108288,0.00003502661,0.00004709504,0.0002164523,0.001258485,0.00006055872,0.0002123581,0.004727627],"study_design_scores_gemma":[0.5466632,0.3569968,0.04414061,0.0001713035,0.04502504,0.00008386352,0.0001939196,0.001970646,0.002413106,0.0003794865,0.001893059,0.00006907701],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899967,0.005521575,0.0008807365,0.0001322276,0.0004088402,0.0008624957,0.0009833594,0.00004550265,0.001168657],"genre_scores_gemma":[0.9953686,0.0007567545,0.0008413581,0.0001514122,0.000218184,0.0008038009,0.0006261336,0.00001310607,0.001220772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006894272,"threshold_uncertainty_score":0.03442973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05842416067394477,"score_gpt":0.3598073883686618,"score_spread":0.301383227694717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}